肺炎相关住院负担:美国2001-2014年
该研究基于美国全国住院患者样本,估算2001-2014年肺炎相关住院的数量与发生率。期间估计有20,361,181例肺炎相关住院,年均年龄调整住院率为464.8/10万(95%CI 462.5-467.1),且该率随时间下降(P<.0001)。住院死亡占7.4%,免疫受损合并比例从2001年18.7%升至2014年29.9%。
要点
- 2001-2014年美国估计有20,361,181例肺炎相关住院,年均年龄调整率464.8/10万。
- 肺炎相关住院的年龄调整发生率在研究期间下降(P<.0001)。
- 合并免疫受损状况的肺炎相关住院比例从2001年18.7%升至2014年29.9%。
核心结论
- 肺炎是美国重要致病和致死原因,不同社会人口群体住院率与结局存在差异,免疫受损人群负担突出。
研究设计与样本
- 使用美国全国住院患者样本(Nationwide Inpatient Sample)估算2001-2014年肺炎相关住院的数量与发生率。
- 肺炎相关住院定义为出院记录中主要诊断为肺炎,或主要诊断为呼吸衰竭或脓毒症时次要诊断为肺炎。
主要发现
- 2001-2014年美国估计有20,361,181例(SE 95,601)肺炎相关住院。
- 年均年龄调整肺炎相关住院率为464.8/10万(95%CI 462.5-467.1),研究期间下降(P<.0001)。
- 住院死亡发生于7.4%(SE 0.03)的肺炎相关住院。
- 非西班牙裔美国印第安/阿拉斯加原住民和非西班牙裔黑人的年均年龄调整住院率最高,分别为439.2/10万(95%CI 415.9-462.5)和438.6/10万(95%CI 432.5-444.7)。
临床怎么用
- 呼吸科应关注肺炎相关住院中免疫受损合并比例上升的趋势,识别高风险人群。
- 对非西班牙裔美国印第安/阿拉斯加原住民和非西班牙裔黑人等住院率较高群体,需进一步评估差异原因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The epidemiology of pneumonia has likely evolved in recent years, reflecting an aging population, changes in population immunity, and socioeconomic disparities. METHODS: Using the National (Nationwide) Inpatient Sample, estimated numbers and rates of pneumonia-associated hospitalizations for 2001-2014 were calculated. A pneumonia-associated hospitalization was defined as one in which the discharge record listed a principal diagnosis of pneumonia or a secondary diagnosis of pneumonia if the principal diagnosis was respiratory failure or sepsis. RESULTS: There were an estimated 20,361,181 (SE, 95,601) pneumonia-associated hospitalizations in the United States during 2001-2014 (average annual age-adjusted pneumonia-associated hospitalization rate of 464.8 per 100,000 population [95% CI, 462.5-467.1]). The average annual age-adjusted pneumonia-associated hospitalization rate decreased over the study period (P < .0001). In-hospital death occurred in 7.4% (SE, 0.03) of pneumonia-associated hospitalizations. Non-Hispanic American Indian/Alaskan Natives and non-Hispanic blacks had the highest average annual age-adjusted rates of pneumonia-associated hospitalization of all race/ethnicities at 439.2 (95% CI, 415.9-462.5) and 438.6 (95% CI, 432.5-444.7) per 100,000 population, respectively. During 2001-2014, the proportion of pneumonia-associated hospitalizations colisting an immunocompromising condition increased from 18.7% (SE, 0.2) in 2001 to 29.9% (SE, 0.2) in 2014. Total charges for pneumonia-associated hospitalizations in 2014 were over $84 billion. CONCLUSIONS: Pneumonia is a major cause of morbidity and mortality in the United States. Differences in rates and outcomes of pneumonia-associated hospitalizations between sociodemographic groups warrant further investigation. The immunocompromised population has emerged as a group experiencing a disproportionate burden of pneumonia-associated hospitalizations.
引用
- Hayes BH, Haberling DL, Kennedy JL, et al. Burden of Pneumonia-Associated Hospitalizations: United States, 2001-2014. Chest. 2017. PMID: 29017956. doi:10.1016/j.chest.2017.09.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。